Results 71 to 80 of about 15,738 (210)
Treatment of patients with allergic conjunctivitis: experience of an outpatient ophthalmologist [PDF]
Клиническая офтальмологияG.A. Azamatova1, G.R. Altynbaeva2 1Bashkir State Medical University, Ufa, Russian Federation 2City Clinical Hospital No. 5 of the city of Ufa, Ufa, Russian Federation Allergic conjunctivitis (AC) is one of the common eye diseases.
G.A. Azamatova, G.R. Altynbayeva
doaj
Revista Alergia México, 2014 Background: Allergic conjunctivitis is an in ammatory disease which involves the conjunctiva, its physiopathology is a type I hypersensitivity (IgE mediated). It is related to the sensitization to indoors and out- doors aeroallergens.
Guillermina Cortés-Morales +3 more
doaj +1 more source
Immunotherapy in allergic conjunctivitis.
Indian journal of ophthalmology, 1992 Eighty patients with allergic conjunctivitis were treated with immunotherapy employing specific allergens. Sixty-two percent of these showed beneficial response. In cases of vernal conjunctivitis needing topical steroid preparations frequently for control of symptoms, immunotherapy is worth attempting to cause remission of symptoms.
Prakash O, Murthy K
openaire +2 more sources
Femtosecond Laser Created Corneal Allogenic Intrastromal Ring Segments for Keratoconus
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Background To evaluate the clinical outcomes of femtosecond laser‐created corneal allogenic intrastromal ring segments (femto‐CAIRS) in keratoconic eyes using a newly described nomogram. Methods This retrospective case series recruited 85 eyes from 75 patients.
David J. Gunn +2 more
wiley +1 more source
Conjunctivitis: Types, Clinical Manifestation and Management
JLUMHSThis narrative review analyses the different types, clinical manifestations, and management strategies for conjunctivitis to facilitate accurate diagnosis and treatment planning.
Mehwish Rubab, Sana Zahoor, Saba Ashraf
doaj +1 more source
Clinical effectiveness of olopatadine therapy in children with allergic conjunctivitis
National Journal of Physiology, Pharmacy and Pharmacology, 2017 Background: Olopatadine hydrochloride is one of the most promising agents with a broad range of pharmacological effects. It has both antihistaminic and mast cell stabilizing properties. It is used in various allergic diseases, and its ophthalmic solution
Scandashree K +3 more
doaj +1 more source
International Journal of Dermatology, EarlyView.ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease with significant physical and psychosocial burden. Dupilumab, a monoclonal antibody targeting IL‐4Rα, has proven to be effective for moderate‐to‐severe AD, but long‐term real‐world data remain limited.
Francesco Leo +11 more
wiley +1 more source
Biomarkers for therapeutic response and adverse outcomes in atopic dermatitis: A systematic review
Journal of the European Academy of Dermatology and Venereology, EarlyView.This review assessed 52 biomarkers predicting systemic therapy response and adverse events in atopic dermatitis. Most studies focused on dupilumab, and findings were inconsistent. IgE and eosinophils were largely non‐predictive, though elevated eosinophils and LDH sometimes indicated poorer outcomes.
Eva Hilger +11 more
wiley +1 more source
Algorithms of Patient Selection for Allergen Immunotherapy
Allergy, EarlyView.
U. Petra Zieglmayer +5 more
wiley +1 more source
Journal of the European Academy of Dermatology and Venereology, EarlyView.This multicentre, observational cohort study in adults and adolescents with atopic dermatitis found that dupilumab treatment provides a higher probability of achieving the treatment targets EASI ≤ 7 and NRS‐pruritus ≤ 4 compared with tralokinumab treatment. Absolute EASI and NRS‐pruritus differences were small among responders.
Lian F. van der Gang +18 more
wiley +1 more source